Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 gamma pseudogene 6 (EEF1GP6) is classified as a pseudogene—a non-functional segment of DNA that resembles a gene involved in protein synthesis, specifically the gamma subunit of eukaryotic translation elongation factor 1. Pseudogenes do not produce functional proteins and are generally regarded as genomic remnants without biological activity. There is no evidence in the literature or databases that EEF1GP6 is expressed, involved in disease, interacts with drugs, or has any role as a therapeutic target. The actual functional gene is EEF1G, a component of the eukaryotic elongation factor complex, which is distinct from pseudogenes such as EEF1GP6.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 gamma pseudogene 6 (EEF1GP6).